The National Human Genome Research Institute (NHGRI) conducts a broad program of laboratory and clinical research to translate genomics into a greater understanding of human biology and develop better methods for the detection, prevention and treatment of heritable and genetic disorders.
The NHGRI Cancer Genetics and Comparative Genomics Branch identifies and study genes that contribute to cancer susceptibility and progression.
The Center for Precision Health Research, formerly Medical Genomics and Metabolic Genetics Branch, studies how health and disease are related to genetic, genomic and metabolic variation.
NHGRI branch focused on computationally intensive approaches to analyze large-scale genomic data and identifying genetic contributions to human disease.
The Genetic Disease Research Branch studies how genetic changes affect the structure and function of gene products leading to human disease.
The Genetics and Molecular Biology Branch uses genomic technologies to study the human genome and other organisms and disease mechanisms.
The Medical Genetics Branch studies inherited disorders of metabolism and of human development.
The Metabolic, Cardiovascular and Inflammatory Disease Genomics Branch studies the genomic and social determinants of complex diseases.
The Metabolic Medicine Branch houses clinical and laboratory research programs that focus on the development of new therapies for patients with genetic disorders.
The Social and Behavioral Research Branch conducts research to apply genomic discoveries to improve health and clinical care.
Last updated: November 10, 2021